How Do Regulatory Considerations Affect Licensing Agreements?
Regulatory considerations play a significant role in cancer-related licensing agreements. The need to comply with complex regulations, such as those imposed by the FDA or the European Medicines Agency, impacts how agreements are structured. These regulations ensure that the development and commercialization of cancer therapies meet safety and efficacy standards, which can influence timelines and financial terms.
